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Abstract
Background: Uterine fibroids are the most common benign tumours affecting premenopausal women and are
often associated with considerable hospitalization and morbidity. Literature shows virtually no study concerning the
quantification of the main factors associated with uterine fibroids in Ghanaian women. The purpose of this study
was to assess the main factors associated with uterine fibroid among Ghanaian women presenting for ultrasound.
Method: A prospective cross-sectional study design was employed in this study. A total of two hundred and forty-
four (244) women were consecutively evaluated from November 2011 to February 2012 using a 2–5 MHz
curvilinear probe of Philips HD3 ultrasound machines at three centres in Accra using a trans-abdominal pelvic
approach. Data was analysed with (SPSS) version 20.0 for windows, 2010; Chicago. The Pearson’s Chi-square test
was used to determine associations between selected demographic and gynaecological characteristics and uterine
fibroid appearance. All tests were two-tailed and p-value of less than 0.05 was interpreted as significant.
Results: The range, mean and standard deviation (SD) of the patients’ age were 14–54 years, 31.89 years and ± 7.92
respectively. Factors that associated significantly with uterine fibroid in Ghanaian women included obesity (X2 =
17.3, p-value = 0.001), participant’s age range (X2 = 47.4, p-value = 0.001), parity (X2 = −10.169, p-value = 0.001), and
age at last delivery (X2 = 34.579, p-value = 0.001).
Conclusion: Uterine fibroid was mainly associated with women of older age group of the reproductive age than
the younger age categories and also associated more with women with without children compared to those with
more children. Moreover, it associated more with obese patients and patient with late age at last delivery.
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Background
Uterine fibroids, also known as uterine leiomyomata, are
mostly benign growths that develop in the muscles of
the uterine wall [1]. They are non-cancerous tumours
which are myometrial in origin [2]. It is uncommon for
fibroids to develop into cancer (leiosarcoma) and occurs
in < 0.1 % of cases [3]. Fibroids grow from tiny uterine
muscle cells and may be initially diagnosed by an im-
aging procedure as small nodules and can grow to larger
sizes where they are palpated through the abdominal
wall with variable sizes even beyond 7.5 cm [4]. Fibroid
can be considered as well-defined masses emanating
from the smooth muscle layer of the uterus and also
composed of extracellular matrix and considered to be
the most common tumour in the female pelvis [5]. Uter-
ine leiomyoma, represent a major public health problem
and the most common benign gynaecologic tumours
affecting premenopausal women [6] and they are often
associated with considerable morbidity [7]. Uterine fi-
broids have also been associated with spontaneous mis-
carriages [8]. They are the most frequent indication for
hysterectomy (abdominal and vaginal), accounting for
approximately one third of all procedures performed
annually in the United States. It is suggested that black
women have a greater fibroid burden than whites [9–12].* Correspondence: Ghana_neo@yahoo.com1Univeristy of Ghana, School of Medicine and Dentistry, P. O. Box GP 4236,
Accra, Ghana
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Uterine leiomyoma, or fibroids, are the most common
tumours of women in the United States, probably occur-
ring in the majority of women by the time they reach
menopause and becoming clinically significant in about
one third of these women [7]. Despite their prevalence,
little attention has been directed toward the aetiology
and pathogenesis of fibroids until recent years because
of the rarity of their malignant transformation [7]. Re-
gardless of their generally benign neoplastic character,
uterine fibroids are responsible for significant morbidity
in a large segment of the female population. The clinical
effects of these tumours are related to their local mass
effect, resulting in pressure upon adjacent organs, exces-
sive uterine bleeding, or problems related to pregnancy,
including infertility and repetitive pregnancy loss [13].
As a consequence of these local pressure effects and
bleeding, uterine fibroids rank as the major reason for
hysterectomy in the United States, accounting for ap-
proximately one-third of all hysterectomies [9] or about
200,000 hysterectomies per year. Although the aetiology
of fibroid is unknown, the scientific literature now
contains a sizeable body of information pertaining to the
epidemiology, genetics, hormonal aspects, and molecular
biology of these tumours.
According to Goodwin & Spies [14], the ovarian hor-
mones oestrogen and progesterone are hypothesized to
enhance fibroid growth [14]. Reported risk factors con-
sistent with the hormonal hypothesis include premeno-
pausal status [15, 16] younger age at menarche [15, 17]
and obesity [15, 18]. Histories of infertility, young age at
first birth, and current alcohol consumption have been
associated with increased risk [15]. Reported protective
factors include parity [15, 17] and oral contraceptive use
[19, 20]. Use of oral contraceptives at young ages was
reported to be associated with an increased risk in at
least one study [17]. Cigarette smoking has been re-
ported to be inversely related to risk in several studies
[15, 21, 22], but not all [23]. These findings stemmed
largely from case control studies among which eligibil-
ity criteria (i.e., age, race, marital status) varied, as did
case definitions (i.e., self-reports; histologic, pathologic,
or ultrasound/hysterectomy confirmation).
Although the initiator or initiators of fibroids are un-
known, several predisposing factors have been identified,
including age (late reproductive years), African-American
ethnicity, nulliparity, and obesity [11]. A population-based
study in the United States found a cumulative incidence
of uterine fibroids of greater than 66 % by ultrasound
examination of women approaching age 50 years [24].
A study by Faerstein [25] showed that parity reduces
risk of fibroid by 20–40 % and the risk further reduces
as parity increases. However, Parrizziani [26] indicated
that induced abortion increases the risk of developing
fibroid nodules. This notwithstanding, a study by Segars
[27] suggested that trauma or a sort of trigger in the
uterus causes uterine cells to contract abnormally and that
could initiate the formation of fibroid nodules. People
with hypertension, atherosclerosis and heart related dis-
ease have shown increased risk of fibroid and by extension
it was noted that high blood pressure was associated with
high risk of clinical diagnosis of fibroid even after giving
the appropriate medical care and treatment for high blood
pressure [28]. According to Wise et al. [29], increase in
age was noted as an outstanding risk factor for uterine
fibroid. In another study, smoking is noted to cause reduc-
tion in the levels of oestrogen and body weight which is
associated with low incidence of fibroids [26]. Further-
more, Baird et al. [30], revealed that physical activity re-
duces the risk of developing fibroid by 40 %. Apart from
the risk factors listed above, there are other factors which
have not been extensively investigated which include en-
vironmental and dietary factors [4].
Literature search both electronic and manual indicated
a gap in terms of documentation on the main factors as-
sociated with uterine fibroids in Ghanaian women. In
Ghana, this gab in information appears to limit some
effort to promote and create awareness on fibroid
among the populace. According to the Ghana Statistical
Service, the female population in Ghana is higher than
the male population, which indicates that the female
population in the work force will also increase. Premen-
opausal women (18–45 years) in Ghana constitute about
40 % of the population [31]. Therefore, more women will
be absent from work due to fibroid related problems if
it is not looked into, which will eventually affect prod-
uctivity and the economy as a whole. It is therefore
imperative to ensure continuous availability of docu-
mented data on the subject that may serve as useful
source of information for policy development and man-
agement of uterine fibroids. It is against this backdrop
that this study was undertaken to assess the associated
factors of uterine fibroid among Ghanaian women pre-
senting for ultrasound scans.
Method
A cross-sectional convenience study, evaluating trans-
abdominal pelvic ultrasound reports generated prospect-
ively in three diagnostic centres in the Accra metropolis,
Ghana was the study design. The centres were chosen
because they had the same equipment models, and large
patient turn over, from across the country. The study
was conducted between November 2011–February 2012.
Two hundred and forty four women in their reproductive
age who were concurrently referred to the centres for
pelvic ultrasound examination on account of suspected
fibroids were recruited for the study. Thus, women who
had attained menopause as well as those yet to attain
menarche were excluded.
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Data analysis
The data collected was collated and analysed using the
Statistical Package for Social Sciences (SPSS) version
20.0 for windows, 2009; Chicago. Descriptive statistics
were calculated. The Pearson’s Chi-square test was used
to determine associations between selected demographic
and gynaecological characteristics and fibroid appear-
ance. All tests were two-tailed and p-value of less than
0.05 was interpreted as significant.
Ethical considerations
In order to ensure that the data from the various interest
groups obtained were handled in an ethical manner, the
following measures were taken. Ethical clearance was
sought and obtained from the Ethics committee of Ghana
Medical School, College of Health Sciences, University of
Ghana. Approval was also sought from the Medical
Directorate of the selected centres.
Because cooperation and commitment of the patients’
involved in the project is crucial, discussions were held
with them prior to the study. This decision was taken
in order to get (i) their individual consent and (ii) to
encourage them to participate voluntarily and encour-
age co-operation.
Since additional data (gynaecological characteristics)
other than that provided on patients’ request forms was
recorded, patients were made aware of the importance
of the study for which data was being taken and the
need for their cooperation and consent. They were also
informed that the data being taken would not in any
way, affect the results of their examination to be done.
Additionally, they were assured of confidentiality of their
identity and the information collected on them. Finally,
patients signed a consent form signifying that they had
agreed to the use of the data collected for research pur-
poses. Those who could not sign gave verbal consent.
Machine/technique and protocol
The ultrasound scanning machines used at the three
study sites were the same. Table 1 shows the characteris-
tics of Ultrasound scanners available in the centres.
Technical specifications of the ultrasound scanning
equipment used in all three (3) centres are shown in
Table 1.
Results
Two-hundred and forty-four (244) patients, who satis-
fied the inclusion criteria, were evaluated by this study.
The age range, mean and standard deviation (SD) of
patients were 14–54 years, 31.9 years and ± 7.9 respect-
ively. Close to half 112 (45.9 %) of the patients were
Akans while only 30 (12.3 %) were from the Northern
region. The patients’ demographics and gynaecological
characteristics are presented in Table 2. From the study,
23 % (38/168) of women <35 had prevalent fibroids,
compared to 67 % (36/54) of women 35–44, and 73 %
(16/22) of women at 45 or above years. Among the eth-
nic groups, 54.5 % of Ga, 37.9 % of Ewes, 32.1 % of Akan
and 26.7 of Northerners’ had uterine fibroids (Fig. 1).
Associations between selected demographics and
presence of uterine fibroids
Table 3 shows associations between selected demographic,
gynecological characteristics and the presence of uterine
fibroids. There was significant positive association be-
tween age group (X2 = 47.4, p-value = 0.001) and BMI
(obesity) (X2 = 17.3, p-value = 0.001) of patients and
presence of uterine fibroids. Parity (χ2 = −10.169, p =
0.001) showed a negative association with fibroids. Other
factor that showed positive association with fibroid was
age at last delivery (X2 = 34.579, p-value = 0.001).
However, presence or otherwise of severe pain during
menstruation (χ2 = 0.471, p = 0.493), type of menstrual
cycle (either regular or irregular) (χ2 = 0.182, p = 0.670),
age at 1st Menstruation (χ2 = 11.19, p = 0.0600) and age
at 1st Delivery (χ2 = 2.456, p = 0.402) were not signifi-
cantly associated with confirmed uterine fibroids.
Discussion
A total of 244 trans-abdominal pelvic ultrasound scan
images of women were analysed. The age range, mean
and standard deviation (SD) of patients were 14–54 years,
31.9 years and ± 7.9 respectively. Prior to the study, 35.2 %
of the sampled participant’s stated that they had been
previously diagnosed to have fibroids. However, during
the study, only 71.1 % of that number were confirmed of
having fibroids. Additionally, out of the 158 patients who
did not know previously of having fibroid, 28.9 % were
confirmed to have fibroid. In general the prevalence or
confirmed rate of the participants having fibroid was
36.9 %. The finding is consistent with available data [14]
which suggest that fibroids are the most common pelvic
tumour in women, causing symptoms in approximately
25 % of reproductive age women with the overall preva-
lence of fibroids increasing to over 70 %.
Table 1 Parameters of the equipment used




Year of manufacture 2005
Probe Curvilinear
Frequency of probe 2–5 MHz
Sarkodie et al. Fertility Research and Practice  (2016) 2:9 Page 3 of 7
From the study, 23 % (38/168) of women <35 had
prevalent fibroids, compared to 67 % (36/54) of women
35–44, and 73 % (16/22) of women at 45 or above years.
This study indicated that the highest prevalence of the
fibroid cases was found among older women in the
reproductive age group. The trend of fibroid prevalence
in this study is consistent with findings of Lurie et al.,
[16] which estimated the prevalence of uterine fibroid as
4 % in women aged 20–30 years, 11 to 18 % in women
between 30–40 years and 33 % in women between
40–60 years. Having fibroids may result in menorrha-
gia, pelvic pain, urinary obstructive symptoms, infer-
tility, and pregnancy loss [20]. The recorded situation
in Ghana is worrying in view of health and other risk
implications. Fibroid has social, economic and medical
implications in the female populace. Premenopausal
women (18–45 years) in Ghana constitute about 40 % of
the Ghanaian population [17] and are strong component
of the country’s workforce and thus contribute immensely
to the economy.
Close to half 112 (45.9 %) of the patients were Akans
ethnic groups. This finding is not surprising because
according to the Ghana Statistical Service [31] Akans
constitutes 47.5 % of the Ghanaian population. Despite
the Akan ethnic group being the majority in this work,
the study also showed that the Ga ethnic grouping
(54.5 %) had the highest percentage of women with fi-
broids. A study by Biritwum, Gyapong and Mensah [32]
indicated that the prevalence of obesity is highest among
the Ga tribe and that could have accounted for the
high incidence of fibroid among them since obesity
is found to be a high risk factor for developing
fibroids.
This study showed significant associations between age
group of patients and the presence of uterine fibroids. The
prevalence increased with increasing age and agrees with
several epidemiologic studies [24, 33]. Thus, it may be
implied that the age of an individual in the reproductive
age plays a vital role in development of fibroids.
Factors that also proved to be associated with fibroid
were age (years) at last delivery and BMI of participants.
The above findings as reported in Table 3 suggest that
uterine fibroid occurrences was common in obese pa-
tients and common in patients with late age at last
delivery.
For BMI, several studies have found an association
between obesity and an increased incidence of uterine
fibroids [7]. This apparent association between obesity
and fibroids may be related to hormonal factors associ-
ated with obesity, but other pathologic pathways might
also be involved. Several relevant hormonal associations
with obesity are known. A significant increase occurs
in the conversion of circulating adrenal androgens to
oestrogen by excess adipose tissue. The hepatic production
of sex hormone-binding globulin is decreased, resulting
in more unbound physiologically active oestrogen. Be-
cause almost all circulating oestrogen postmenopausally
are derived from metabolism of circulating androgens
by peripheral tissues, including fat, these two mechanism
probably have more impact in premenopausal women
[34]. In obese premenopausal women, decreased
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metabolism of estradiol by the 2-hydroxylation route re-
duces the conversion of estradiol to inactive metabolites,
which could result in a relatively hyper oestrogenic state
[35].
The negative association between parity and the risk
of fibroids in this study is consistent with the findings in
previous studies [26, 36, 37]. An explanation for this
finding is that pregnancy reduces the time of exposure
to unopposed oestrogens, whereas nulliparity or reduced
fertility may be associated with an ovulatory cycle char-
acterized by long term unopposed oestrogens. The alter-
nate possibility exist that uterine fibroids are actually the
Fig. 1 Confirmed fibroid distribution among the ethnic groups
Table 3 Factors associated with uterine fibroids among participants diagnosed of having fibroids and their levels of significance
Characteristic Confirmed diagnosis of fibroids in participants χ2
value
P-
valueYes (%) No (%)
Age Range 14–24 0 (0) 44 (28.6) 47.4 0.001
25–34 years 38 (42.2) 130 (84.4)
35–44 years 36 (40.0) 18 (11.7)
45 years and above 16 (17.8) 6 (3.9)
BMI Normal 18 (20.0) 56 (36.8) 17.3 0.001
Overweight 22 (24.4) 52 (34.2)
Obese 50 (55.6) 44 (28.9)
Parity Zero/Nulliparous 44 (48.9) 44 (28.6) −10.169 0.001
1 and above 46 (51.1) 110 (71.4)
Age at 1st Menstruation Less than 12 years 2 (2.4) 8 (6.1) 11.191 0.0600
12–15 years 44 (53.7) 94 (71.2)
16 years and above 36 (43.9) 30 (22.7)
Age (Years) at Last Delivery of Participants Nulliparous 42 (46.7) 100 (64.9) 14.603 0.004
<24 years 6 (6.7) 18 (11.7)
25–29 years 14 (15.6) 14 (9.1)
30 years and above 28 (31.1) 22 (14.3)
Type of Menstrual Cycle of Participants (Irregular Cycle) Yes 62 (68.9) 102 (66.2) 0.182 0.670
No 28 (31.1) 52 (33.8)
Presence of severe pains during menstruation Yes 62 (68.9) 82 (53.2) 0.471 0.493
No 38 (42.2) 72 (46.8)
Age at 1st Delivery Less than 18 years 4 (8.3) 6 (11.1) 2.456 0.402
18–34 years 42 (87.5) 48 (88.9)
35 years and above 2 (4.2) 0 (0.0)
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cause of infertility, rather than the consequence of it;
however, the diminished association of fibroids with parity
remains essentially the same after exclusion of women
with a history of infertility [14].
Meanwhile, factors such as presence or otherwise of
severe pain during menstruation and type of menstrual
cycle of participants (either regular or irregular), age at
1st Menstruation and age at 1st Delivery did not show
any statistical significance. These findings suggest that
the aforementioned factors are not necessarily factors
that are commonly associated with uterine fibriod among
Ghanaian women in this study.
Conclusion
The study concludes that uterine fibroid in Ghanaian
women is mainly associated with women of older age
group of the reproductive age than the younger age
categories and also associates more with women with no
children as compared to those with more children.
Moreover, it associates more with obese patients and pa-
tient with late age at last delivery. The Ghanaian woman
is engaged in governmental and non-governmental busi-
nesses, which has seen a tremendous growth which is an
indication that women are gradually taking up more
equally demanding responsibilities aside their traditional
roles. Therefore, managing the health of the Ghanaian
woman is essential for the socio-economic growth of the
country. The findings may aid in appropriate interven-
tions and policy planning in the country.
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